Suppresses absorption of Chromium. This medication is commonly used for Weight Loss
Chromium has an adjacent metabolic rationale with GLP-1 use because of its relationship with insulin action and glucose metabolism. Meta-analyses of randomized trials in people with type 2 diabetes have reported improvements in fasting glucose, insulin, HbA1c, and insulin-resistance measures with chromium supplementation, although results vary substantially across studies. Importantly, evidence does not consistently support chromium for weight or fat loss, so it should not be positioned as a weight-loss enhancer. Chromium picolinate is one of the most extensively studied supplemental forms for metabolic support.
Asbaghi O, Fatemeh N, Rezaei Kelishadi M, Ghaedi E, Eslampour E, Nazarian B, Ashtary-Larky D, Alavi Naeini A. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2020;161:105098. Georgaki MN, Tsokkou S, Keramas A, Papamitsou T, Karachrysafi S, Kazakis N. Chromium supplementation and type 2 diabetes mellitus: an extensive systematic review. Environ Geochem Health. 2024;46(12):515. Vajdi M, et al. Effects of chromium supplementation on body composition in patients with type 2 diabetes: A dose-response systematic review and meta-analysis of randomized controlled trials. J Trace Elem Med Biol. 2024;81:127338. Alkhalidi F. A comparative study to assess the use of chromium in type 2 diabetes mellitus. J Med Life. 2023;16(8):1178-1182.
Chromium Picolinate — 200 mcg
Chromium deficiency has been linked to higher cardiovascular risk because low chromium status can impair both glucose and lipid metabolism, driving compensatory hyperinsulinemia that promotes atherogenic changes over time. Studies have reported markedly lower plasma chromium levels in patients with established coronary artery disease compared with healthy controls, suggesting that inadequate chromium may be more common in people with overt atherosclerosis. Mechanistically, chromium insufficiency can worsen insulin resistance, elevate circulating insulin, and contribute to dyslipidemia, supporting the idea that unrecognized chromium deficiency may act as an upstream, modifiable risk factor in the development and progression of cardiovascular disease.
Chromium Picolinate by Pure Encapsulations — 200 mcg
Prolonged use of Exenatide can leave gaps in your nutrition. A targeted supplement can help restore balance while you continue treatment.

A bespoke formula designed to replenish the nutrients depleted by Exenatide.
Once Daily Capsule · Rx Not Required
Learn More